Collaboration for the Management of Hydroxychloroquine

James T. Rosenbaum; Karen H. Costenbader; Julianna Desmarais; Ellen M. Ginzler; Nicole Fett; Susan M. Goodman; James R. O'Dell; Gabriela Schmajuk; Victoria P. Werth; Ronald B. Melles; Michael F. Marmor

doi:10.1016/j.ophtha.2021.02.015

Collaboration for the Management of Hydroxychloroquine

James T. Rosenbaum, Karen H. Costenbader, Julianna Desmarais, Ellen M. Ginzler, Nicole Fett, Susan M. Goodman, James R. O'Dell, Gabriela Schmajuk, Victoria P. Werth, Ronald B. Melles, Michael F. Marmor

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	1115-1116
Number of pages	2
Journal	Ophthalmology
Volume	128
Issue number	7
DOIs	https://doi.org/10.1016/j.ophtha.2021.02.015
State	Published - Jul 2021

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1016/j.ophtha.2021.02.015

Cite this

@article{fe1cf141711e46fa8004966120a335d1,

title = "Collaboration for the Management of Hydroxychloroquine",

author = "Rosenbaum, {James T.} and Costenbader, {Karen H.} and Julianna Desmarais and Ginzler, {Ellen M.} and Nicole Fett and Goodman, {Susan M.} and O'Dell, {James R.} and Gabriela Schmajuk and Werth, {Victoria P.} and Melles, {Ronald B.} and Marmor, {Michael F.}",

note = "Funding Information: The author(s) have made the following disclosure(s): J.T.R.: Consultant – AbbVie, UCB, Gilead, Novartis, Horizon, Roche, Eyevensys, Santen, Corvus, Affibody, Kyverna; Financial support – Pfizer, Horizon; Royalties – UpToDate K.H.C.: Consultant – Neutrolis, Merck; Financial support – Merck, Janssen, Astra Zeneca, GSK; Equity owner – Alkermes, Generex; Royalties – UpToDate E.M.G.: Consultant – AbbVie; Financial support – Aurina, Lilly, GSK N.F.: Financial support – Lilly and Pfizer; Royalties – UpToDate S.M.G.: Consultant – UCB, Pfizer; Financial support – Horizon Pharma, Novartis, Pfizer V.P.W.: Consultant – Celgene, Medimmune, Resolve, Genentech, Idera, Janssen, Lilly, Pfizer, Biogen, BMS, Gilead, Amgen, Medscape, Nektar, Incyte, EMD Serona, CSL Behring, Principia, Crisalis, Viela Bio, Argenx, Kirin, Regeneron, Principia, AstraZeneca, Abbvie, Octapharma, GSK, Astra-Zeneca; Financial support – Celgene, Janssen, Pfizer, Biogen, Gilead, Corvus Pharmaceuticals, Genentech, AstraZeneca, Viela, Syntimmune; University of Pennsylvania owns the copyright for the CLASI and CDASI",

year = "2021",

month = jul,

doi = "10.1016/j.ophtha.2021.02.015",

language = "English (US)",

volume = "128",

pages = "1115--1116",

journal = "Ophthalmology",

issn = "0161-6420",

publisher = "Elsevier Inc.",

number = "7",

}

TY - JOUR

T1 - Collaboration for the Management of Hydroxychloroquine

AU - Rosenbaum, James T.

AU - Costenbader, Karen H.

AU - Desmarais, Julianna

AU - Ginzler, Ellen M.

AU - Fett, Nicole

AU - Goodman, Susan M.

AU - O'Dell, James R.

AU - Schmajuk, Gabriela

AU - Werth, Victoria P.

AU - Melles, Ronald B.

AU - Marmor, Michael F.

N1 - Funding Information: The author(s) have made the following disclosure(s): J.T.R.: Consultant – AbbVie, UCB, Gilead, Novartis, Horizon, Roche, Eyevensys, Santen, Corvus, Affibody, Kyverna; Financial support – Pfizer, Horizon; Royalties – UpToDate K.H.C.: Consultant – Neutrolis, Merck; Financial support – Merck, Janssen, Astra Zeneca, GSK; Equity owner – Alkermes, Generex; Royalties – UpToDate E.M.G.: Consultant – AbbVie; Financial support – Aurina, Lilly, GSK N.F.: Financial support – Lilly and Pfizer; Royalties – UpToDate S.M.G.: Consultant – UCB, Pfizer; Financial support – Horizon Pharma, Novartis, Pfizer V.P.W.: Consultant – Celgene, Medimmune, Resolve, Genentech, Idera, Janssen, Lilly, Pfizer, Biogen, BMS, Gilead, Amgen, Medscape, Nektar, Incyte, EMD Serona, CSL Behring, Principia, Crisalis, Viela Bio, Argenx, Kirin, Regeneron, Principia, AstraZeneca, Abbvie, Octapharma, GSK, Astra-Zeneca; Financial support – Celgene, Janssen, Pfizer, Biogen, Gilead, Corvus Pharmaceuticals, Genentech, AstraZeneca, Viela, Syntimmune; University of Pennsylvania owns the copyright for the CLASI and CDASI

PY - 2021/7

Y1 - 2021/7

UR - http://www.scopus.com/inward/record.url?scp=85103000819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85103000819&partnerID=8YFLogxK

U2 - 10.1016/j.ophtha.2021.02.015

DO - 10.1016/j.ophtha.2021.02.015

M3 - Editorial

C2 - 33752915

AN - SCOPUS:85103000819

SN - 0161-6420

VL - 128

SP - 1115

EP - 1116

JO - Ophthalmology

JF - Ophthalmology

IS - 7

ER -

Collaboration for the Management of Hydroxychloroquine

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this